Diagnostic Center | March 09, 2022
SRL Diagnostics report indicates women neglect routine tests
Routine tests undertaken by women dropped by 35% in 2020
Routine tests undertaken by women dropped by 35% in 2020
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Collaboration in the industry needs to be institutionalised to drive the growth.
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
Subscribe To Our Newsletter & Stay Updated
